NCT06025175

Brief Summary

This study will include 60 elderly patients with cervical disc degeneration, from both gender who are aged from 60 - 75 years old.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
60

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Sep 2023

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 20, 2023

Completed
17 days until next milestone

First Posted

Study publicly available on registry

September 6, 2023

Completed
9 days until next milestone

Study Start

First participant enrolled

September 15, 2023

Completed
16 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

October 1, 2023

Completed
3 months until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2024

Completed
Last Updated

September 6, 2023

Status Verified

September 1, 2023

Enrollment Period

16 days

First QC Date

August 20, 2023

Last Update Submit

September 2, 2023

Conditions

Disc Degeneration

Outcome Measures

Primary Outcomes (1)

  • Resistivity index of both right and left vertebral arteries

    Resistivity index of both right and left vertebral arteries will be measured before and after the 12 weeks.

    12 weeks

Study Arms (2)

Lazer group

EXPERIMENTAL

30 patients will receive low level lazer therapy 3 times per week for 12 weeks.

Radiation: Low level Lazer therapyOther: Routine exercises

Control group

OTHER

30 patients will receive only exercises.

Other: Routine exercises

Interventions

Low level Lazer therapyRADIATION

30 patients will receive low level lazer therapy 3 times a week for 12 weeks.

Lazer group
Routine exercisesOTHER

30 patients will receive only routine exercises 3 times a week for 12 weeks.

Control groupLazer group

Eligibility Criteria

Age60 Years - 75 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • elderly patients with age range between 60 and 75 years old.
  • with cervical disc degeneration.

You may not qualify if:

  • patients with uncontrolled hypertension.
  • Patients with uncontrolled diabetes mellitus.
  • Patients with severe cardiac or chest diseases.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Shymaa yussuf abo zaid

Qina, Egypt

Location

MeSH Terms

Conditions

Intervertebral Disc Degeneration

Condition Hierarchy (Ancestors)

Spinal DiseasesBone DiseasesMusculoskeletal Diseases

Central Study Contacts

Shymaa Y Abo zaid

CONTACT

01010941685shaymaayoussef397@gmail.com

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Two groups Group (A) and group(B)
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Lecturer

Study Record Dates

First Submitted

August 20, 2023

First Posted

September 6, 2023

Study Start

September 15, 2023

Primary Completion

October 1, 2023

Study Completion

January 1, 2024

Last Updated

September 6, 2023

Record last verified: 2023-09

Locations

EG(1)